[Isl] ISL BLOG - The FDA's controversial approval of drug to treat Alzheimer's disease

[Willard Edmonds]

[cid:image001.png at 01D76CF1.061422A0]

The FDA recently approved a drug to treat Alzheimer’s disease, but the decision triggered controversy.

In the ISL Blog, Neil Charness, Director of the Institute for Successful Longevity, explains why the FDA’s decision stunned some researchers.

You can read his ISL Blog contribution here:  https://isl.fsu.edu/blog.

Bill Edmonds, Ph.D.
Institute for Successful Longevity
Florida State University
850-933-7960
btedmond at fsu.edu<mailto:btedmond at fsu.edu>

  [cid:image001.png at 01D47128.6CBD68D0]

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.fsu.edu/pipermail/isl/attachments/20210629/2ad5cad0/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 15571 bytes
Desc: image001.png
URL: <http://lists.fsu.edu/pipermail/isl/attachments/20210629/2ad5cad0/attachment.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.png
Type: image/png
Size: 54997 bytes
Desc: image002.png
URL: <http://lists.fsu.edu/pipermail/isl/attachments/20210629/2ad5cad0/attachment-0001.png>